Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of Pudafensine in vulvodynia (provoked vestibulodynia) is currently recruiting. Sponsored by Initiator Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvodynia

Drugs mentioned

• Pudafensine

Snippet

Sponsor: Initiator Pharma | Conditions: Vulvodynia | Phase 2 | Status: RECRUITING